Literature DB >> 2945865

The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells.

C Morimoto, N L Letvin, C E Rudd, M Hagan, T Takeuchi, S F Schlossman.   

Abstract

The molecular basis for the suppression generated in a concanavalin A (Con A)-activated T cell culture remains unknown. In this study, we have attempted to determine whether the 2H4 and 4B4 molecules on Con A-activated T cells play some role in the generation of suppression by such cells. We have shown that Con A-activated suppressor cells belong to the 2H4+ subset of T cells but not the 4B4+ (2H4-) subset. Con A-activated T cells exerted their optimal suppressor function on day 2 in culture, a time at which the expression of 2H4 on such cells was maximal and 4B4 was minimal. Furthermore, the stimulation of T cells with the higher concentration of Con A generated the stronger suppressor function. At the same time, both 2H4 expression and density were increased and 4B4 expression and density were decreased on such Con A-activated T cells. More importantly, the treatment of Con A-activated T cells with anti-2H4 antibody but not with anti-4B4, anti-TQ1, or anti-T4 antibodies can block the suppressor function of such cells. Taken together, the above results strongly suggest that the 2H4 molecule itself may be involved in the generation of suppressor function in Con A-activated T cells. The 2H4 antigen on such cells was shown to be comprised of 220,000 and 200,000 m.w. glycoproteins. Thus this study indicates that the 220,000 and 200,000 m.w. structure of the 2H4 molecule may itself play a crucial role in the generation of suppressor signals of Con A-activated cells.

Mesh:

Substances:

Year:  1986        PMID: 2945865

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis.

Authors:  M Zaffaroni; S Rossini; A Ghezzi; R Parma; C L Cazzullo
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

2.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

3.  Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluid.

Authors:  S Dominique; F Bouchonnet; J M Smiéjan; A J Hance
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

Review 4.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

5.  Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis.

Authors:  P F Life; N J Viner; P A Bacon; J S Gaston
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

Review 6.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

7.  Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis.

Authors:  A N Akbar; A Timms; G Janossy
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

8.  Alterations in helper-inducer and suppressor-inducer T-cell subsets in human neonatal blood.

Authors:  R Landesberg; M Fallon; R Insel
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

9.  Age-related changes in surface antigens on peripheral lymphocytes of healthy children.

Authors:  Y Osugi; J Hara; H Kurahashi; N Sakata; M Inoue; K Yumura-Yagi; K Kawa-Ha; S Okada; A Tawa
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

10.  Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes.

Authors:  M D Gorrell; M R Brandon; D Sheffer; R J Adams; O Narayan
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.